hVIVO to Present at the Canaccord Genuity 36th Annual Growth Conference
(firmenpresse) - LONDON, UNITED KINGDOM -- (Marketwired) -- 08/04/16 -- hVIVO plc (AIM: HVO), the pioneer of human disease models, today announced that it will be presenting at the Canaccord Genuity 36th Annual Growth Conference in Boston, on Wednesday, August 10, 2016 at 1:30 p.m. ET.
A live audio webcast of the presentation will be available in the section of the hVIVO website at . A webcast replay will be available on the website for 90 days following the live presentation.
About hVIVO
hVIVO plc ("hVIVO") is a life sciences company pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, RSV, asthma and common cold. hVIVO has commercialised four disease models, successfully enrolled more than 2,000 subjects and conducted over 45 product validation studies for a wide range of industry, government and academic clients and collaborators. For more information, please visit , , and .
For further information, please contact:
hVIVO plc
+44 207 756 1300
Kym Denny
Chief Executive Officer
Graham Yeatman
Chief Financial & Business Officer
Media Enquiries
+44 203 021 3933 / +44 7854 979 420
Colin Paterson
Director of Marketing, Communication and Public Relations
Numis Securities Limited
+44 207 260 1000
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.08.2016 - 14:30 Uhr
Sprache: Deutsch
News-ID 1450969
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
LONDON, UNITED KINGDOM
Phone:
Kategorie:
Biotech
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 184 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"hVIVO to Present at the Canaccord Genuity 36th Annual Growth Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
HVIVO PLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
